Chemical formula: C₁₄H₁₃N₃O₄S₂ Molecular mass: 351.401 g/mol PubChem compound: 54677470
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam family, with anti-inflammatory, analgesic and antipyretic properties. The anti-inflammatory activity of meloxicam has been proven in classical models of inflammation. As with other NSAID, its precise mechanism of action remains unknown. However, there is at least one common mode of action shared by all NSAID (including meloxicam): inhibition of the biosynthesis of prostaglandins, known inflammation mediators.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
ATC code | Group title | Classification |
---|---|---|
M01AC06 | Meloxicam | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AC Oxicams |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Title | Information Source | Document Type | |
---|---|---|---|
MOBIC Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
MELOXICAM Orodispersible tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Meloxicam is an active ingredient of these brands:
Australia (AU)Ecuador (EC)
Finland (FI)France (FR)Germany (DE)Hong Kong (HK)Japan (JP)Lithuania (LT)Mexico (MX)
Poland (PL)Spain (ES)Turkey (TR)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.